Category: Chimeric antigen receptor (CAR) t-cell therapy
In this episode, we’re joined by Dr. Marc Hoffmann from The University of Kansas Cancer Center, to explore chronic lymphocytic […]
Primary Central Nervous System Lymphoma (PCNSL) is a rare form of non-Hodgkin lymphoma that affects the brain, spinal cord, or […]
Curious about CAR T-cell therapy? We went straight to the source for answers. In this episode, the LLS Patient Education […]
In this episode, we sit down with Dr. Bilal Abid from University of Texas Health Science Center in Houston to […]
Living with chronic lymphocytic leukemia (CLL) can be a challenging journey for both patients and caregivers. However, there is a […]
The treatment landscape for non-Hodgkin lymphoma has significantly evolved over the past few decades. With groundbreaking advancements in CAR T-cell […]
Explore the cutting-edge of oncology as we delve into the revolutionary world of CAR T-cell therapy, a more recent medical […]
Remarkable progress has been made in the treatment of myeloma over the past decade, giving patients and families much hope […]
Please join us as we speak about CAR T-cell therapy with Dr. Carlos Silva, a Moffitt Cancer physician at Memorial […]
Join us as we speak to Laurie Adami, a follicular lymphoma (non-Hodgkin lymphoma) survivor. In this episode, Laurie shares her […]
Please join us as we speak to Dr. Matthew Davids of Dana-Farber Cancer Institute. In this episode, Dr. Davids discusses […]
Join us as we speak to Dr. Benjamin Lampson of Dana-Farber Cancer Institute in Boston, MA. In Part Two of […]
Join us as we speak with Charles Huang and Dr. Gabriel Mannis in honor of AML Awareness Day (April 21st). […]
Join us as we speak to Dr. Eunice Wang, the Chief of Leukemia Service and Professor of Oncology at Roswell […]
Join us in this next installment of our series, Patient-Doctor Perspectives, where we explore a diagnosis from the view of a […]
Join us as we speak to Dr. Caron Jacobson, an Assistant Professor of Medicine at Harvard Medical School and a […]
Join us as we report on the latest developments in immunotherapy from the 62nd American Society of Hematology (ASH) Annual […]
They say hindsight is always 20/20. Looking back, Tim Card remembers how his body may have been sending signals that […]
On this episode, Alicia and Lizette speak with Chuck Colletti, a two-time survivor of Stage 4 follicular lymphoma. Chuck was […]
On this episode, Alicia and Lizette speak with Dr. Rayne H. Rouce. Dr. Rouce is a pediatric hematologist and oncologist […]
Join Alicia and Lizette as they speak with Dr. Rayne H. Rouce. Dr. Rouce is a pediatric hematologist and oncologist […]
Like any therapy that is administered in oncology, there is great promise but also, unfortunately, several toxicities and side effects […]